Clincosm LogoSign in Get a demo

Haemophilia A

Showing 26 - 50 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +69 more
Jul 27, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in China (turoctocog alfa)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Beijing, Beijing, China
  • +10 more
Jul 24, 2020

QoL Impairment, Including Pain, Depression and Anxiety, in

Completed
  • Haemophilia A
  • Haemophilia B
    • Copenhagen, Denmark
    • +4 more
    Jul 16, 2020

    Haemophilia A Trial in Worldwide (Turoctocog alfa)

    Terminated
    Has Results
    • Haemophilia A
    • Turoctocog alfa
    • Wien, Austria
    • +13 more
    Jul 2, 2020

    Turoctocog Alfa During Long-Term Treatment of Severe and

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Mobile, Alabama
    • +40 more
    Apr 24, 2020

    Congenital Bleeding Disorder, Haemophilia A Trial in India (turoctocog alfa)

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Bangalore, Karnataka, India
    • +9 more
    Apr 16, 2020

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa pegol
    • Orlando, Florida
    • +18 more
    Jan 31, 2020

    Brain Development, Thinking and Behaviour in Hemophilia

    Completed
    • Haemophilia A
    • Haemophilia B
    • No treatment given
    • Los Angeles, California
    • +21 more
    Nov 21, 2019

    Haemophilia A Trial in France (Thrombin generation measurement.)

    Unknown status
    • Haemophilia A
    • Thrombin generation measurement.
    • Bordeaux, France
    • +6 more
    Jul 9, 2019

    Congenital Bleeding Disorder, Haemophilia A, Healthy Trial in Worldwide (NNC172-2021)

    Terminated
    • Congenital Bleeding Disorder
    • +2 more
    • Wien, Austria
    • +5 more
    May 14, 2019

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Worldwide (NNC 0172-0000-2021, )

    Completed
    • Congenital Bleeding Disorder
    • +3 more
    • NNC 0172-0000-2021
    • placebo
    • Wien, Austria
    • +15 more
    May 14, 2019

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Chicago, Illinois
    • +14 more
    Jan 29, 2019

    Haemophilia A Trial in Poland, United Kingdom (Optivate® (Human Coagulation Factor VIII))

    Completed
    • Haemophilia A
    • Optivate® (Human Coagulation Factor VIII)
    • Debinki 7, 80-211 Gdansk, Poland
    • +7 more
    Feb 14, 2018

    Haemophilia A Trial in Poland (Optivate® (Human Coagulation Factor VIII))

    Completed
    • Haemophilia A
    • Optivate® (Human Coagulation Factor VIII)
    • W. Chodzki Str., Lublin, Poland
    • +4 more
    Feb 14, 2018

    Haemophilia A Trial in Poland, United Kingdom (Optivate® (Human Coagulation Factor VIII))

    Completed
    • Haemophilia A
    • Optivate® (Human Coagulation Factor VIII)
    • Bialystok, Poland
    • +10 more
    Feb 14, 2018

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa pegol
    • Torrance, California
    • +13 more
    Dec 14, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Phoenix, Arizona
    • +56 more
    Jun 27, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Concizumab, )

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • Torrance, California
    • +33 more
    Jul 20, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Little Rock, Arkansas
    • +62 more
    Feb 9, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Phoenix, Arizona
    • +37 more
    Feb 9, 2017

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Worldwide (eptacog alfa (activated), vatreptacog alfa

    Completed
    Has Results
    • Congenital Bleeding Disorder
    • +2 more
    • eptacog alfa (activated)
    • vatreptacog alfa (activated)
    • Los Angeles, California
    • +44 more
    Jan 23, 2017

    Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Harrow (NNC172-2021, )

    Completed
    • Congenital Bleeding Disorder
    • +3 more
    • Harrow, United Kingdom
      Novo Nordisk Investigational Site
    Feb 23, 2017

    Living With Haemophilia

    Completed
    • Congenital Bleeding Disorder
    • +5 more
    • No treatment given
    • Mississauga, Canada
    • +2 more
    Feb 20, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Kuala Lumpur, London (turoctocog alfa)

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • turoctocog alfa
    • Kuala Lumpur, Malaysia
    • +2 more
    Feb 9, 2017

    Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Advate®, turoctocog alfa)

    Completed
    • Congenital Bleeding Disorder
    • Haemophilia A
    • Berlin, Germany
    • +6 more
    Feb 9, 2017